Now on home page
NASA/ADS
Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer
- Shah, Manish A.
;
- Wainberg, Zev A.
;
- Catenacci, Daniel V. T.
;
- Hochster, Howard S.
;
- Ford, James
;
- Kunz, Pamela
;
- Lee, Fa-Chyi
;
- Kallender, Howard
;
- Cecchi, Fabiola
;
- Rabe, Daniel C.
;
- Keer, Harold
;
- Martin, Anne-Marie
;
- Liu, Yuan
;
- Gagnon, Robert
;
- Bonate, Peter
;
- Liu, Li
;
- Gilmer, Tona
;
- Bottaro, Donald P.
- Publication:
-
PLoS ONE
- Pub Date:
- March 2013
- DOI:
-
10.1371/journal.pone.0054014
- Bibcode:
-
2013PLoSO...854014S
🌓